Sarepta turns negative despite Q1 beats; 2026 guidance maintained
Sarepta Therapeutics,, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $17.61
-24% in 7d after detection
Post-detection moves
1h
—
1d
-9.7%
3d
-16%
7d
-24%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS